Fed. Circ. Reverses Patent Priority Rulings On Protein

Law360, New York (September 8, 2010, 3:46 PM EDT) -- A federal appeals court has ruled that a patent application must do more than simply allow someone skilled in a field to envision an invention in order to lay claim to priority to the technology, reversing two interference decisions over an antiviral protein.

The U.S. Court of Appeals for the Federal Circuit gave priority on two interferences related to human fibroblast interferon to David V. Goeddel and Roberto Crea on Tuesday, overturning decisions by the U.S. Patent and Trademark Office's Board of Patent Appeals and Interferences....
To view the full article, register now.